- Home
- ZCMD vs EDSA Comparison
ZCMD vs EDSA Comparison
Compare ZCMD & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZCMD
- EDSA
- Stock Information
- Founded
- ZCMD 2012
- EDSA 2015
- Country
- ZCMD China
- EDSA Canada
- Employees
- ZCMD N/A
- EDSA N/A
- Industry
- ZCMD Other Consumer Services
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- ZCMD Real Estate
- EDSA Health Care
- Exchange
- ZCMD Nasdaq
- EDSA Nasdaq
- Market Cap
- ZCMD 29.0M
- EDSA 13.8M
- IPO Year
- ZCMD 2020
- EDSA N/A
- Fundamental
- Price
- ZCMD $1.17
- EDSA $2.08
- Analyst Decision
- ZCMD
- EDSA Strong Buy
- Analyst Count
- ZCMD 0
- EDSA 2
- Target Price
- ZCMD N/A
- EDSA $13.00
- AVG Volume (30 Days)
- ZCMD 649.8K
- EDSA 15.4K
- Earning Date
- ZCMD 01-01-0001
- EDSA 08-08-2025
- Dividend Yield
- ZCMD N/A
- EDSA N/A
- EPS Growth
- ZCMD N/A
- EDSA N/A
- EPS
- ZCMD N/A
- EDSA N/A
- Revenue
- ZCMD $15,864,773.00
- EDSA N/A
- Revenue This Year
- ZCMD N/A
- EDSA N/A
- Revenue Next Year
- ZCMD N/A
- EDSA N/A
- P/E Ratio
- ZCMD N/A
- EDSA N/A
- Revenue Growth
- ZCMD N/A
- EDSA N/A
- 52 Week Low
- ZCMD $0.95
- EDSA $1.55
- 52 Week High
- ZCMD $2.97
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- ZCMD 48.27
- EDSA 55.28
- Support Level
- ZCMD $1.10
- EDSA $1.99
- Resistance Level
- ZCMD $1.30
- EDSA $2.11
- Average True Range (ATR)
- ZCMD 0.15
- EDSA 0.11
- MACD
- ZCMD -0.01
- EDSA 0.02
- Stochastic Oscillator
- ZCMD 22.52
- EDSA 72.41
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.